Cambria Pharmaceuticals Announces $5.4 Million Series A Financing
4/22/2008 7:44:38 AM
More...
|
Cambria Biosciences' Chemical Genetics Platform is Featured in Nature Article Describing a New Pharmaceutical Mode of Action
3/13/2008 8:45:49 AM
More...
|
Cambria Biosciences Receives $5.0 Million in Grants and Awards for Neurodegenerative Disease Drug Discovery and Preclinical Development Programs
11/12/2007 11:38:18 AM
More...
|
Cambria Biosciences Announces Collaboration with Pfizer Animal Health in Antiparasitic Drug Discovery
6/7/2007 12:31:39 PM
More...
|
Cambria Biosciences Unveils Novel Epilepsy Drug Discovery Program at the Neurotechnology Industry Organization Conference
5/18/2007 2:23:16 AM
More...
|
Cambria Biosciences Presents New Screening Model For Epilepsy Drug Discovery At Society For Neuroscience Meeting
10/16/2006 11:24:15 AM
More...
|
Cambria Biosciences' Innovative Technology Yields New Understanding Of Insecticide Mode Of Action
8/7/2006 4:47:35 PM
More...
|
Cambria Biosciences Awarded Three Small Business Innovation Research Grants From National Institutes of Health (NIH) For Company's Neurodegenerative Disease Program
10/19/2005 5:12:41 PM
More...
|
Cambria Biosciences Announces Milestones In Insecticide Discovery Collaboration With Dow Agrosciences
10/19/2005 5:12:26 PM
More...
|
Cambria Biosciences Announces Discovery Collaboration With Syngenta (SYT)
10/19/2005 5:09:00 PM
More...
|